• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

两例经皮心脏装置手术后皮下血肿中使用克食痹蠲丸的效果。

Effective Use of Keishibukuryogan in Subcutaneous Hematoma after Implantable Cardiac Device Surgery in Two Cases.

机构信息

Division of Cardiovascular Medicine, Department of Internal Medicine, Kurume University School of Medicine, Japan.

出版信息

Intern Med. 2021 Mar 1;60(5):755-759. doi: 10.2169/internalmedicine.5677-20. Epub 2020 Oct 7.

DOI:10.2169/internalmedicine.5677-20
PMID:33028772
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7990628/
Abstract

Keishibukuryogan is a Kampo medicine that induces vasodilation and improves the blood flow velocity in subcutaneous blood vessels. We herein report two cases in which keishibukuryogan completely diminished subcutaneous hematoma after cardiac resynchronization therapy pacemaker implantation and defibrillator battery replacement within a month. Keishibukuryogan can be a good option for treating or preventing subcutaneous hematoma after surgical procedures for devices.

摘要

救心丹是一种汉方药，可引起血管扩张并改善皮下血管的血流速度。我们在此报告两例患者，在心脏再同步治疗起搏器植入和除颤器电池更换术后 1 个月内，救心丹完全消除了皮下血肿。救心丹可作为治疗或预防装置手术后皮下血肿的一种选择。

相似文献

1
Effective Use of Keishibukuryogan in Subcutaneous Hematoma after Implantable Cardiac Device Surgery in Two Cases.两例经皮心脏装置手术后皮下血肿中使用克食痹蠲丸的效果。
Intern Med. 2021 Mar 1;60(5):755-759. doi: 10.2169/internalmedicine.5677-20. Epub 2020 Oct 7.
2
Complications arising from cardiac implantable electrophysiological devices: review of epidemiology, pathogenesis and prevention for the clinician.心脏植入式电生理设备引发的并发症：临床医生对流行病学、发病机制及预防的综述
Postgrad Med. 2016;128(2):223-30. doi: 10.1080/00325481.2016.1151327. Epub 2016 Feb 22.
3
Risk factors for early replacement of cardiovascular implantable electronic devices.心血管植入式电子装置早期更换的危险因素。
Int J Cardiol. 2015 Jan 15;178:99-101. doi: 10.1016/j.ijcard.2014.10.157. Epub 2014 Oct 25.
4
Cardiac implantable electronic device and vascular access: Strategies to overcome problems.心脏植入式电子设备与血管通路：克服问题的策略
J Vasc Access. 2018 Nov;19(6):521-527. doi: 10.1177/1129729818762981. Epub 2018 Mar 19.
5
Use of a pocket compression device for the prevention and treatment of pocket hematoma after pacemaker and defibrillator implantation (STOP-HEMATOMA-I).使用口袋式压迫装置预防和治疗起搏器及除颤器植入术后的口袋血肿（STOP-HEMATOMA-I）。
J Interv Card Electrophysiol. 2017 Aug;49(2):197-204. doi: 10.1007/s10840-017-0235-9. Epub 2017 Apr 17.
6
Quality and Safety in Health Care, Part XLIV: Cardiac Resynchronization Therapy and Subcutaneous Defibrillator Implantable Devices.医疗保健中的质量和安全，第四十四部分：心脏再同步治疗和皮下除颤器可植入设备。
Clin Nucl Med. 2019 Feb;44(2):119-120. doi: 10.1097/RLU.0000000000002136.
7
Sub-pocket small-hole drainage for pocket hematoma after cardiac device implantation.心内器械植入后囊袋血肿的亚囊袋小切口引流
Herz. 2022 Feb;47(1):63-66. doi: 10.1007/s00059-021-05037-y. Epub 2021 Apr 22.
8
Pocket haematoma after cardiac electronic device implantation in patients receiving antiplatelet and anticoagulant treatment: a single-centre experience.接受抗血小板和抗凝治疗的患者植入心脏电子设备后发生的皮下血肿：单中心经验
Acta Cardiol. 2017 Feb;72(1):47-52. doi: 10.1080/00015385.2017.1281539.
9
Risk of hematoma complications after device implant in the clopidogrel era.氯吡格雷时代器械植入后血肿并发症风险。
Circ Arrhythm Electrophysiol. 2010 Aug;3(4):312-8. doi: 10.1161/CIRCEP.109.917625. Epub 2010 Jun 17.
10
Current strategies to minimize postoperative hematoma formation in patients undergoing cardiac implantable electronic device implantation: A review.当前减少接受心脏植入式电子设备植入术患者术后血肿形成的策略：综述。
Heart Rhythm. 2021 Apr;18(4):641-650. doi: 10.1016/j.hrthm.2020.11.017. Epub 2020 Nov 23.

引用本文的文献

1
A Review on the Mechanism and Application of Keishibukuryogan.关于柴胡桂枝干姜汤作用机制及应用的综述
Front Nutr. 2021 Dec 24;8:760918. doi: 10.3389/fnut.2021.760918. eCollection 2021.

本文引用的文献

1
Device-Pocket Hematoma After Cardiac Implantable Electronic Devices.心脏植入式电子设备后的设备囊袋血肿
Circ Arrhythm Electrophysiol. 2020 Apr;13(4):e008372. doi: 10.1161/CIRCEP.120.008372. Epub 2020 Mar 20.
2
Effect of Keishibukuryogan, a Japanese Traditional Kampo Prescription, on Improvement of Microcirculation and Oketsu and Induction of Endothelial Nitric Oxide: A Live Imaging Study.日本传统汉方制剂桂枝茯苓丸对微循环和瘀血改善及内皮型一氧化氮诱导的影响：一项活体成像研究
Evid Based Complement Alternat Med. 2017;2017:3620130. doi: 10.1155/2017/3620130. Epub 2017 Jul 13.
3
Pocket haematoma after cardiac electronic device implantation in patients receiving antiplatelet and anticoagulant treatment: a single-centre experience.
接受抗血小板和抗凝治疗的患者植入心脏电子设备后发生的皮下血肿：单中心经验
Acta Cardiol. 2017 Feb;72(1):47-52. doi: 10.1080/00015385.2017.1281539.
4
Use of a pocket compression device for the prevention and treatment of pocket hematoma after pacemaker and defibrillator implantation (STOP-HEMATOMA-I).使用口袋式压迫装置预防和治疗起搏器及除颤器植入术后的口袋血肿（STOP-HEMATOMA-I）。
J Interv Card Electrophysiol. 2017 Aug;49(2):197-204. doi: 10.1007/s10840-017-0235-9. Epub 2017 Apr 17.
5
Impact of haematoma after pacemaker and CRT device implantation on hospitalization costs, length of stay, and mortality: a population-based study.起搏器和 CRT 设备植入术后血肿对住院费用、住院时间和死亡率的影响：一项基于人群的研究。
Europace. 2015 Oct;17(10):1548-54. doi: 10.1093/europace/euv075. Epub 2015 Apr 7.
6
Examination of clinical efficacy of keishibukuryogan on non-specific complaints associated with varicose veins of the lower extremity.考察桂枝茯苓丸对下肢静脉曲张相关非特异性症状的临床疗效。
Ann Vasc Dis. 2014;7(3):266-73. doi: 10.3400/avd.oa.14-00055. Epub 2014 Jul 30.
7
The traditional Japanese formula keishibukuryogan inhibits the production of inflammatory cytokines by dermal endothelial cells.传统的日本方剂“keishibukuryogan”可抑制皮肤内皮细胞产生炎症细胞因子。
Mediators Inflamm. 2010;2010:804298. doi: 10.1155/2010/804298. Epub 2010 Dec 28.
8
Pocket hematoma after pacemaker or implantable cardioverter defibrillator surgery: influence of patient morbidity, operation strategy, and perioperative antiplatelet/anticoagulation therapy.起搏器或植入式心脏复律除颤器手术后的皮下血肿：患者发病率、手术策略及围手术期抗血小板/抗凝治疗的影响
Chest. 2004 Oct;126(4):1177-86. doi: 10.1378/chest.126.4.1177.